2m 2m 2m 2m 2m 2m 2m
INHIBIKASE THRP (IKT)
NASDAQ
$1.86-$0.01 (-0.53%)
Price as of Jun 24, 2026 6:30 PM EDT- $246.9MMarket Cap
- 11.98%1-Year Change
- BiotechnologyIndustry
INHIBIKASE THRP (IKT)
$1.86-$0.01 (-0.53%)
Earnings Score
Valuation | IKT | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | 0 | ||
Growth | 0 | ||
Low Earnings Volatility | 3 |
Momentum Score
Valuation | IKT | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | -6.11% | ||
12-Month Momentum | 1.81% | ||
3-Month Risk Adjusted Momentum | -21.58% | ||
12-Month Risk Adjusted Momentum | 2.53% |
True Yield
Valuation | IKT | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | N/A | ||
Net Debt Paydown Yield | 0.03% |
Financial Health Score
Valuation | IKT | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | -11 |